Abstract
Introduction: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia. Herein, we sought to identify potential immune-related therapeutic targets in ITP. Methods: The differentially expressed genes (DEGs) between ITP patients and controls in GSE43177 and PRJNA299534 were analyzed. The intersections of the two DEG groups were screened as common genes, and enrichment analysis was performed. Additionally, differential analysis of immune cell levels between ITP and controls was performed. Changes in the proportions of T follicular helper (Tfh) and follicular regulatory T (Tfr) cells in peripheral blood samples from ITP patients, ITP patients responding to therapy, and healthy controls were identified. The expression changes in B-cell lymphoma (Bcl)-6 and interleukin (IL)-21 were further evaluated. Results: A total of 76 common genes were identified, and enrichment analysis found that these genes were mainly associated with neutrophil-mediated immunity, the MAPK signaling pathway, and the FOXO signaling pathway. Furthermore, we found different levels of Tfh cells in patients with ITP and controls. The level of Tfh cells in the peripheral blood is significantly increased in ITP patients and declines after responding to therapy. The Tfr/Tfh ratio was reduced in ITP patients and increased after responding to therapy. IL-21 and Bcl-6 were more highly expressed in ITP patients than in controls. Conclusion: We identified abnormally expressed genes in ITP related to immune-related biological functions. We further identified the changes in Tfh and Tfr cells during ITP treatment. This provides a rationale for immunotherapy in ITP patients.
Journal Section:
Original Paper
References
1.
Provan
D
, Stasi
R
, Newland
AC
, Blanchette
VS
, Bolton-Maggs
P
, Bussel
JB
et al. International consensus report on the investigation and management of primary immune thrombocytopenia
. Blood
. 2010
;115
(2
):168
–86
.2.
Swinkels
M
, Rijkers
M
, Voorberg
J
, Vidarsson
G
, Leebeek
FWG
, Jansen
AJG
. Emerging concepts in immune thrombocytopenia
. Front Immunol
. 2018
;9
:880
.3.
Chen
WT
, Tang
RM
, Huang
Y
, Pan
YP
, Wang
SW
, Wang
GY
. Different Chinese herbal medicine therapy for idiopathic thrombocytopenic purpura: a protocol for systematic review and Bayesian network meta-analysis
. Medicine
. 2021
;100
(13
):e25341
.4.
Singh
A
, Uzun
G
, Bakchoul
T
. Primary immune thrombocytopenia: novel insights into pathophysiology and disease management
. J Clin Med
. 2021
;10
(4
):789
.5.
Ahmed
HAW
, Masoud
AT
, Han
J
, Adel Sofy
A
, Saeed Ahmed
A
, Abdesattart
AT
et al. Eltrombopag effectiveness and tolerability in chronic immune thrombocytopenia: a meta-analysis
. Clin Appl Thromb Hemost
. 2021
;27
:10760296211005555
.6.
Venkatadri
R
, Sabapathy
V
, Dogan
M
, Mohammad
S
, Harvey
SE
, Simpson
SR
et al. Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T-follicular helper cells and germinal center B cells
. Eur J Immunol
. 2022
;52
(5
):825
–34
.7.
Dai
L
, He
L
, Wang
Z
, Bai
X
, He
Y
, Cao
L
et al. Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia
. Exp Ther Med
. 2018
;16
(3
):2471
–7
.8.
Xia
X
, Yang
J
, Wang
S
. Follicular regulatory T cells in systemic lupus erythematosus
. J Immunol Res
. 2021
;2021
:1
–9
.9.
Cui
Y
, Guan
Y
, Liu
W
, Li
Y
, Li
H
, Guo
M
. [The changes of circulating follicular regulatory T cells and follicular T helper cells in children immune thrombocytopenia]
. Zhonghua Xue Ye Xue Za Zhi
. 2014
;35
(11
):980
–4
.10.
Choi
J
, Diao
H
, Faliti
CE
, Truong
J
, Rossi
M
, Belanger
S
et al. Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits
. Nat Immunol
. 2020
;21
(7
):777
–89
.11.
Long
D
, Chen
Y
, Wu
H
, Zhao
M
, Lu
Q
. Clinical significance and immunobiology of IL-21 in autoimmunity
. J Autoimmun
. 2019
;99
:1
–14
.12.
Zhang
Q
, Bai
H
, Wang
W
. Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura
. Cell Biol Int
. 2014
;38
(4
):520
–5
.13.
Ritchie
ME
, Phipson
B
, Wu
D
, Hu
Y
, Law
CW
, Shi
W
et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies
. Nucleic Acids Res
. 2015
;43
(7
):e47
.14.
Anders
S
, Huber
W
. Differential expression analysis for sequence count data
. Genome Biol
. 2010
11
10
R106
.15.
Yu
G
, Wang
LG
, Han
Y
, He
QY
. clusterProfiler: an R package for comparing biological themes among gene clusters
. OMICS
. 2012
;16
(5
):284
–7
.16.
Miao
YR
, Zhang
Q
, Lei
Q
, Luo
M
, Xie
GY
, Wang
H
et al. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy
. Adv Sci
. 2020
;7
(7
):1902880
.17.
Neunert
C
, Noroozi
N
, Norman
G
, Buchanan
GR
, Goy
J
, Nazi
I
et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
. J Thromb Haemost
. 2015
;13
(3
):457
–64
.18.
Emilsson
V
, Thorleifsson
G
, Zhang
B
, Leonardson
AS
, Zink
F
, Zhu
J
et al. Genetics of gene expression and its effect on disease
. Nature
. 2008
;452
(7186
):423
–8
.19.
Shimazu
Y
, Uchiyama
T
, Mizumoto
C
, Takeoka
T
, Tsuji
M
, Tomo
K
et al. Concurrent autoimmune neutropenia and idiopathic thrombocytopenic purpura associated with IgG4-related diease
. Intern Med
. 2018
;57
(13
):1911
–6
.20.
Zhao
Y
, Ni
X
, Xu
P
, Liu
Q
, Sun
T
, Liu
X
et al. Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP)
. Cytokine
. 2020
;125
:154853
.21.
Fan
Z
, Wang
X
, Li
P
, Mei
C
, Zhang
M
, Zhao
C
et al. Systematic identification of lncRNA-associated ceRNA networks in immune thrombocytopenia
. Comput Math Methods Med
. 2020
;2020
:6193593
.22.
Peng
HL
, Zhang
Y
, Sun
NN
, Yin
YF
, Wang
YW
, Cheng
Z
et al. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia
. J Thromb Haemost
. 2017
;15
(11
):2259
–69
.23.
Kostic
M
, Zivkovic
N
, Cvetanovic
A
, Marjanovic
G
. CD4(+) T cell phenotypes in the pathogenesis of immune thrombocytopenia
. Cell Immunol
. 2020
;351
:104096
.24.
Wang
CM
, Luo
Y
, Wang
YC
, Sheng
GY
. [Roles of follicular helper T cells and follicular regulatory T cells in pathogenesis of Henoch-Schonlein purpura in children]
. Zhongguo Dang Dai Er Ke Za Zhi
. 2015
;17
(10
):1084
–7
.25.
Zhu
Y
, Zou
L
, Liu
YC
. T follicular helper cells, T follicular regulatory cells and autoimmunity
. Int Immunol
. 2016
;28
(4
):173
–9
.26.
Gong
Y
, Tong
J
, Wang
S
. Are follicular regulatory T cells involved in autoimmune diseases
. Front Immunol
. 2017
;8
:1790
.27.
Ding
Y
, Li
J
, Yang
P
, Luo
B
, Wu
Q
, Zajac
AJ
et al. Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice
. Arthritis Rheumatol
. 2014
;66
(9
):2601
–12
.28.
Hetta
HF
, Elkady
A
, Yahia
R
, Meshall
AK
, Saad
MM
, Mekky
MA
et al. T follicular helper and T follicular regulatory cells in colorectal cancer: a complex interplay
. J Immunol Methods
. 2020
;480
:112753
.29.
Nurieva
RI
, Chung
Y
, Martinez
GJ
, Yang
XO
, Tanaka
S
, Matskevitch
TD
et al. Bcl6 mediates the development of T follicular helper cells
. Science
. 2009
;325
(5943
):1001
–5
.30.
Wang
Q
, Li
J
, Yu
TS
, Liu
Y
, Li
K
, Liu
S
et al. Disrupted balance of CD4(+) T-cell subsets in bone marrow of patients with primary immune thrombocytopenia
. Int J Biol Sci
. 2019
;15
(13
):2798
–814
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
